Poland· PL-100323639

Pediaven G20

A lösungen zur parenteralen ernährung, kombinationen product containing produkt złożony, registered in Poland by Fresenius Kabi Polska Sp. z o.o.. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedPediaven G20ATCB05BA10REGISTER NO.PL-100323639PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Lösungen zur parenteralen ernährung, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA10 (lösungen zur parenteralen ernährung, kombinationen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Lösungen zur parenteralen ernährung, kombinationen · ATC B05BA10

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Produkt złożony
Manufacturer
Fresenius Kabi Polska Sp. z o.o.
Country
Poland (PL)
ATC code
B05BA10
ATC class
Lösungen zur parenteralen Ernährung, Kombinationen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991185374

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for lösungen zur parenteralen ernährung, kombinationen.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lösungen zur parenteralen ernährung, kombinationen · interactions on record

6 records

  • 2 severe
  • 4 moderate

Most severe, free to view

  • ErdafitinibL01EN01severe
  • ErdafitinibL01EX16severe
  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b6630327-cd6f-49e0-a5e6-3113cdc59ebc
GET /v1/drugs/b6630327-cd6f-49e0-a5e6-3113cdc59ebc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Roztwór do infuzji",
  "source": "urpl",
  "strength": "-",
  "packaging": "05909991185374 ¦ Lz ¦ 103271\n4 worki 1000 ml",
  "substance": "Alaninum 1.93 g + Arginina 1.26 g + Acetylcysteinum 0.42 g + Glutamic acid 2.17 g + Glicyna 0.64 g + Histidinum 0.64 g + izoleucyna 0.95 g + Leucinum 2.14 g + Lisinum monohydricum 1.93 g + Methioninum 0.4 g + Phenylalaninum 0.83 g + prolina 1.72 g + Serinum 1.16 g + Tauryna 0.09 g + Treoninum 1.1 g + Tryptophanum 0.43 g + Tyrosine 0.15 g + Valinum 1.1 g + Dipotasu fosforan 1.39 g + Glucosum monohydricum 220 g + wapnia glukonian 2.69 g + Magnesii lactas 0.95 g + Sodu chlorek 1.75 g + Kalii chloridum 0.67 g + Zinci acetas dihydras 6.72 mg + Cupri sulfas pentahydricus 1 mg + sodu fluorek 1.11 mg + Mangani chloridum 0.36 mg + Kalii iodidum 0.07 mg + Chromium chloride hexahydricum 0.1 mg + Ferrosi sulfas heptahydricus 2.49 mg + kobaltu chlorek 0.61 mg",
  "common_name": "Produkt złożony",
  "pl_product_id": "100323639",
  "pozwolenie_nr": "22022",
  "auth_procedure": "DCP",
  "authorisation_validity": "2026-04-11"
}

See everything about lösungen zur parenteralen ernährung, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.